Public Health Decision Support

This chapter presents potential uses of information and communication technologies (ICTs) for public health, with a special focus on decision-making and decisional support systems. An overview of public health sub-domains is given as potential functional areas for ICTs and business intelligence. The specifics and principles of decision-making for public health policy are explained. Main methods and observational tools used in epidemiology are overviewed. Relevant decisional support architectures are presented, ranging from data warehouse techniques, geographical information systems and simulation tools. The relevance and reusability of medico-administrative data sources is discussed, and balanced with data from registries and cohort studies in the perspective of evidence-based decisional support systems for public health. Last, public health decisional support systems are discussed as tools for translational research in public health.

[1]  H. Graham,et al.  Where is the future in public health? , 2010, The Milbank quarterly.

[2]  G. Bevan,et al.  "Systematic" , 1966, Comput. J..

[3]  A. Bauman,et al.  Translating research for evidence-based public health: key concepts and future directions , 2012, Journal of Epidemiology & Community Health.

[4]  M. Vanhoorne,et al.  Occupational Health Care for the 21st Century: From Health at Work to Workers' Health , 2006, International journal of occupational and environmental health.

[5]  Nicholas C. Ide,et al.  The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.

[6]  R. Lozano,et al.  Elements for a theory of the health transition. , 1991, Health transition review : the cultural, social, and behavioural determinants of health.

[7]  J. Bryce,et al.  Evidence-based public health: moving beyond randomized trials. , 2004, American journal of public health.

[8]  H. Quan,et al.  Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. , 2008, Health services research.

[9]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[10]  D J Barker,et al.  What is epidemiology? , 1978, British medical journal.

[11]  Stephen Eubank,et al.  in silico Surveillance: evaluating outbreak detection with simulation models , 2013, BMC Medical Informatics and Decision Making.

[12]  A. Andermann,et al.  Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. , 2008, Bulletin of the World Health Organization.

[13]  Surajit Chaudhuri,et al.  An overview of data warehousing and OLAP technology , 1997, SGMD.

[14]  Marie Haring Sweeney,et al.  Public health surveillance data: legal, policy, ethical, regulatory, and practical issues. , 2012, MMWR supplements.

[15]  Paul Landais,et al.  The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  Christian Jacquelinet,et al.  The French Organ Transplant Data System , 2005, MIE.

[17]  D. Altman,et al.  Statistics Notes: Diagnostic tests 1: sensitivity and specificity , 1994 .

[18]  M. Minkler,et al.  Health Education, Health Promotion and the Open Society: An Historical Perspective , 1989, Health education quarterly.

[19]  Philip Scott,et al.  Simplifying HL7 Version 3 messages , 2011, MIE.

[20]  T. Greene.  Randomized and observational studies in nephrology: how strong is the evidence? , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  H. Delatte,et al.  Evidence of diversity and recombination in Arsenophonus symbionts of the Bemisia tabaci species complex , 2012, BMC Microbiology.

[22]  D. Raisch,et al.  Comparisons of Food and Drug Administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: report of the International Society for Pharmacoeconomics and outcomes research risk benefit management working group. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[23]  R. Brownson,et al.  How do we more effectively move epidemiology into policy action? , 2012, Annals of epidemiology.

[24]  K. Blake,et al.  Increasing scientific standards, independence and transparency in post‐authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance , 2012, Pharmacoepidemiology and drug safety.

[25]  M. Krönke,et al.  Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak , 2012, BMC Microbiology.

[26]  C. Winslow,et al.  PUBLIC HEALTH AT THE CROSSROADS. , 1926, American journal of public health.

[27]  G. Anderson,et al.  A comparison of single- and multi-payer health insurance systems and options for reform. , 2003, Health policy.

[28]  Colin Robertson,et al.  Review of software for space-time disease surveillance , 2010, International journal of health geographics.

[29]  D. Florin,et al.  Scientific uncertainty and the role of expert advice: the case of health checks for coronary heart disease prevention by general practitioners in the UK. , 1999, Social science & medicine.

[30]  L. Elveback,et al.  Simulation of mathematical models for public health problems. , 1965, Public health reports.

[31]  N. Danchin,et al.  Impact of Free Universal Medical Coverage on Medical Care and Outcomes in Low-Income Patients Hospitalized for Acute Myocardial Infarction: An Analysis From the French National Health Insurance System , 2011, Circulation. Cardiovascular quality and outcomes.

[32]  T. Pruett,et al.  A Consolidated Biovigilance System for Blood, Tissue and Organs: One Size Does Not Fit All , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  E. Zerhouni.  Translational and clinical science--time for a new vision. , 2005, The New England journal of medicine.

[34]  A. Weill,et al.  French national health insurance information system and the permanent beneficiaries sample. , 2010, Revue d'epidemiologie et de sante publique.

[35]  N. Black,et al.  Evidence based policy: proceed with care. , 2001, BMJ : British Medical Journal.

[36]  Neil Pearce,et al.  Classification of epidemiological study designs. , 2012, International journal of epidemiology.

[37]  L. Walters.  Genetics and bioethics: How our thinking has changed since 1969 , 2012, Theoretical Medicine and Bioethics.

[38]  Gordon Rs,et al.  An operational classification of disease prevention. , 1983 .

[39]  David Mellor,et al.  Common Warehouse Metamodel: An Introduction to the Standard for Data Warehouse Integration , 2001 .

[40]  Anu Maria,et al.  Introduction to modeling and simulation , 1997, WSC '97.

[41]  R. Maclennan.  Cancer registration: principles and methods. Items of patient information which may be collected by registries. , 1991, IARC scientific publications.

[42]  Armin Koch,et al.  Personalized medicine using DNA biomarkers: a review , 2012, Human Genetics.

[43]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[44]  Ana Simonet,et al.  A Multi-Source Information System via the Internet for End-Stage Renal Disease: Scalability and Data Quality , 2005, MIE.